Aptevo Therapeutics
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2401 4th Ave Ste 1050, Seattle, Washingt...Phone Number
(206) 838-0500Website
www.aptevotherapeutics.comRevenue
-Stock Symbol
APVOIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
2
1
About Aptevo Therapeutics
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company headquartered in Seattle, Washington, focused on developing bispecific and trispecific immunotherapies for cancer. Its pipeline is built on proprietary ADAPTIR and ADAPTIR-FLEX protein technology platforms designed to create multispecific antibody candidates that enhance immune responses against cancer cells. Its lead candidate, mipletamig, is being evaluated in a Phase 1b/2 trial for frontline acute myeloid leukemia in combination with venetoclax and azacitidine. Aptevo also develops additional candidates for solid tumors and blood cancers and trades on Nasdaq under the ticker APVO.Explore more
Aptevo Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aptevo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Aptevo Therapeutics has new funding data
Check out if Aptevo Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Aptevo Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Aptevo Therapeutics recently announced quarterly report
Aptevo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Aptevo Therapeutics
Product Launch: Get notified when Aptevo Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Aptevo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Aptevo Therapeutics
Find 3 more new buyers
Compare Similar Companies to Aptevo Therapeutics
Compare insights from companies similar to Aptevo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$123.9M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Company Profile Activity
Activity Insights
Aptevo Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aptevo Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aptevo Therapeutics.
Aptevo Therapeutics financials insights
Gather financial insights about Aptevo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Debt
$35M
2025
Other Financing Round
$2M
Share Placement
$2M
2026
Grant
$1.5M
Stock/Share Issuance
$3.5M
Aptevo Therapeutics Tech Stack
A closer look at the technologies used by Aptevo Therapeutics
See more technologies
Most Recent Scoops
Person-Based
General Counsel
Funding
Funding
Person-Based
Person-Based
Business Finance, Finance, Financing & Debt
Person-Based
Clinical Operations
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aptevo Therapeutics
Sign Up For FreeTo access detailed company insights
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company headquartered in Seattle, Washington, focused on developing bispecific and trispecific immunotherapies for cancer. Its pipeline is built on proprietary ADAPTIR and ADAPTIR-FLEX protein technology platforms designed to create multispecific antibody candidates that enhance immune resp... Read More
